SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma

Human clinical studies investigating use of convalescent plasma (CP) for treatment of coronavirus disease 2019 (COVID-19) have produced conflicting results. Outcomes in these studies may vary at least partly due to different timing of CP administration relative to symptom onset. The mechanisms of ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Deere, Jesse D., Carroll, Timothy D., Dutra, Joseph, Fritts, Linda, Sammak, Rebecca Lee, Yee, JoAnn L., Olstad, Katherine J., Reader, J. Rachel, Kistler, Amy, Kamm, Jack, Di Germanio, Clara, Shaan Lakshmanappa, Yashavanth, Elizaldi, Sonny R., Roh, Jamin W., Simmons, Graham, Watanabe, Jennifer, Pollard, Rachel E., Usachenko, Jodie, Immareddy, Ramya, Schmidt, Brian A., O’Connor, Shelby L., DeRisi, Joseph, Busch, Michael P., Iyer, Smita S., Van Rompay, Koen K. A., Hartigan-O’Connor, Dennis J., Miller, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612156/
https://www.ncbi.nlm.nih.gov/pubmed/34817208
http://dx.doi.org/10.1128/Spectrum.01397-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612156/
https://www.ncbi.nlm.nih.gov/pubmed/34817208
http://dx.doi.org/10.1128/Spectrum.01397-21

Ejemplares similares